M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
HOPE Therapeutics secures financing to expand interventional psychiatry clinics
Clinical-stage biopharmaceutical company NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) announced on Tuesday that its wholly-owned subsidiary HOPE Therapeutics, Inc., a development stage healthcare delivery company, has signed a Stock Purchase Agreement (SPA) with Smith & Sauer, LLC to initiate a USD27....
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search